APR 27, 2017 2:41 PM PDT

Cheap Drug Drastically Cuts Maternal Deaths

WRITTEN BY: Xuan Pham

A drug created created in the 1960s is now credited as a powerful tool that can save thousands of women from bleeding to death during and after childbirth.

In an international trial that included 20,000 women in 21 countries, researchers found that the drug called tranexamic acid drastically reduced the risks of women dying from postpartum hemorrhage. The condition of heavy bleeding after childbirth affects 100,000 women every year, making it the biggest cause of maternal death worldwide.

Tranexamic stops heavy bleeding by inhibiting the breakdown of blood clots. The drug slashed deaths related to hemorrhaging by 31 percent in women given the drug within three hours of childbirth.

In addition to its impressive effectiveness, researchers are also praising the drug’s cheap cost and minimal side effects. The drug is estimated to cost $3 in the UK, and even less in other countries, such as Pakistan.

"We found an inexpensive drug, given in a single shot, that reduces the risk of bleeding to death, and it should play a role in reducing maternal mortality around the world,” said Ian Roberts, one of the researchers.

"If you can save a life for approximately $3, then I believe that's worth doing," added Haleema Shakur, who directs clinical trials at the London School of Tropical Medicine and Hygiene.

Interestingly enough, the drug that’s now being lauded as a game-changer for preventing childbirth deaths was nearly all but forgotten since it was invented in the 1960s by a Japanese husband-wife pair, Shosuke and Utako Okamoto. According to Shakur, "It was Okamoto's dream to save women. But she couldn't convince doctors to test the drug on postpartum hemorrhaging."

Instead, the drug was marketed as treatment for heavy periods. If it wasn’t for the efforts of Shakur and colleagues, the drug may not have been resurrected for such a powerful purpose.

For Ukato Okamoto, it is never too late to save lives. "We wanted to work on something international, we wanted to discover new drugs to show our gratitude to humanity," she said of her and her husband’s goals decades ago. "We thought that would be wonderful."

Additional sources: BBC

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
NOV 05, 2019
Clinical & Molecular DX
NOV 05, 2019
Meningitis and Encephalitis: Testing & Diagnosis Strategies for Effective Treatment
Meningitis is an inflammation of the membranes surrounding the brain (meninges) and spinal cord. Encephalitis, on the other hand, refers to inflammation of...
NOV 10, 2019
Microbiology
NOV 10, 2019
A New Strain of HIV is Identified
For the first time since 2000, researchers have identified a new subtype of HIV....
JAN 15, 2020
Clinical & Molecular DX
JAN 15, 2020
Laser microchip picks up cancer markers in urine
A future where patients no longer need to endure expensive, painful and complicated cancer tests could soon become a reality. Researchers have developed a...
FEB 07, 2020
Clinical & Molecular DX
FEB 07, 2020
New diagnostic technology uses levitating proteins
Intrinsic biophysical properties of proteins hold valuable clues about how they function and their role in disease. Take, for example, one of the most comm...
MAR 12, 2020
Clinical & Molecular DX
MAR 12, 2020
Molecular biomarker in saliva predicts childhood obesity
Epigenetic changes modify how genes are switched on and off, without altering DNA’s genetic code sequence. These epigenetic variations are reversible...
MAR 30, 2020
Clinical & Molecular DX
MAR 30, 2020
Imaging Platform to Aid in Diagnosis of COVID-19
In the exponential growth of a rapidly spreading infectious disease, healthcare systems become overwhelmed, which can have a cascade of negative effects....
Loading Comments...